IL-2 production by virus- and tumor-specific human CD8 T cells is determined by their fine specificity

被引:24
作者
Mallard, E
Vernel-Pauillac, F
Velu, T
Lehmann, F
Abastado, JP
Salcedo, M
Bercovici, N
机构
[1] Univ Paris 06, LUTI, Immuno Designed Mol Res Lab, F-75006 Paris, France
[2] Free Univ Brussels, Dept Erasme Bordet Med Oncol, B-1050 Brussels, Belgium
关键词
D O I
10.4049/jimmunol.172.6.3963
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Memory CD8 T cells mediate rapid and effective immune responses against previously encountered Ags. However, these cells display considerable phenotypic and functional heterogeneity. In an effort to identify parameters that correlate with immune protection, we compared cell surface markers, proliferation, and cytokine production of distinct virus- and tumor-specific human CD8 populations. Phenotypic analysis of epitope-specific CD8 T cells showed that Ag specificity is associated with distinct CCR7/CD45RA expression profiles, suggesting that Ag recognition drives the expression of these molecules on effector/memory T cells. Moreover, the majority of central memory T cells (CD45RA(low)CCR7(dull)) secreting cytokines in response to an EBV epitope produces both IL-2 and IFN-gamma, whereas effector memory CD8 cells (CD45RA(dull)CCR7(-)) found in EBV, CMV, or Melan-A memory pools are mostly composed of cells secreting exclusively IFN-gamma. However, these various subsets, including Melan-A-specific effector memory cells differentiated in cancer patients, display similar Ag-driven proliferation in vitro. Our findings show for the first time that human epitope-specific CD8 memory pools differ in IL-2 production after antigenic stimulation, although they display similar intrinsic proliferation capacity. These results provide new insights in the characterization of human virus- and tumor-specific CD8 lymphocytes.
引用
收藏
页码:3963 / 3970
页数:8
相关论文
共 41 条
[1]   Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients:: Role of common γ-chain cytokines [J].
Anichini, A ;
Scarito, A ;
Molla, A ;
Parmiani, G ;
Mortarini, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (04) :2134-2141
[2]   Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections [J].
Appay, V ;
Dunbar, PR ;
Callan, M ;
Klenerman, P ;
Gillespie, GMA ;
Papagno, L ;
Ogg, GS ;
King, A ;
Lechner, F ;
Spina, CA ;
Little, S ;
Havlir, DV ;
Richman, DD ;
Gruener, N ;
Pape, G ;
Waters, A ;
Easterbrook, P ;
Salio, M ;
Cerundolo, V ;
McMichael, AJ ;
Rowland-Jones, SL .
NATURE MEDICINE, 2002, 8 (04) :379-385
[3]  
Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO
[4]  
2-K
[5]   Multiparameter precursor analysis of T-cell responses to antigen [J].
Bercovici, N ;
Givan, AL ;
Waugh, MG ;
Fisher, JL ;
Vernel-Pauillac, F ;
Ernstoff, MS ;
Abastado, JP ;
Wallace, PK .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 276 (1-2) :5-17
[6]   A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory [J].
Bourgeois, C ;
Rocha, B ;
Tanchot, C .
SCIENCE, 2002, 297 (5589) :2060-2063
[7]   T cell affinity maturation by selective expansion during infection [J].
Busch, DH ;
Pamer, EG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) :701-709
[8]   Skewed maturation of memory HIV-specific CD8 T lymphocytes [J].
Champagne, P ;
Ogg, GS ;
King, AS ;
Knabenhans, C ;
Ellefsen, K ;
Nobile, M ;
Appay, V ;
Rizzardi, GP ;
Fleury, S ;
Lipp, M ;
Förster, R ;
Rowland-Jones, S ;
Sékaly, RP ;
McMichael, AJ ;
Pantaleo, G .
NATURE, 2001, 410 (6824) :106-111
[9]   A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3 [J].
Coulie, PG ;
Karanikas, V ;
Colau, D ;
Lurquin, C ;
Landry, C ;
Marchand, M ;
Dorval, T ;
Brichard, V ;
Boon, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10290-10295
[10]   Observing the invisible: successful tumor immunity in humans [J].
Darnell, RB ;
Posner, JB .
NATURE IMMUNOLOGY, 2003, 4 (03) :201-201